Furthermore, KIF2C expression was correlated to increased tumor grading [142,153], staging [98], RFS [98,150], DFS [98,141,144,151,153] (Figure 3(D), DSF; mean HR 1.81 [1.20–2.61]), differentiation of the tumor [144], relapse [144], and immune cell infiltration [102]. The gene discussed is KIF2C; the disease is neoplasm.